US keeps estrogen patches off its shortage list amid back orders

The US FDA has not added estradiol patches to its drug shortage list, though it says it is working with all six manufacturers to raise supply. Pharmacists' group ASHP has listed the menopause patches as short since January, while Reuters reported shortages spreading to estrogen injections and creams. Three US senators have asked the FDA to respond by November 16.